BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20584582)

  • 1. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques.
    Palma DA; Senan S; Haasbeek CJ; Verbakel WF; Vincent A; Lagerwaard F
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):506-13. PubMed ID: 20584582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer.
    Badellino S; Muzio JD; Schivazappa G; Guarneri A; Ragona R; Bartoncini S; Trino E; Filippi AR; Fonio P; Ricardi U
    Br J Radiol; 2017 Oct; 90(1078):20170143. PubMed ID: 28749172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.
    Oechsner M; Odersky L; Berndt J; Combs SE; Wilkens JJ; Duma MN
    Radiat Oncol; 2015 Dec; 10():249. PubMed ID: 26626865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiotherapy: volumetric modulated arc therapy versus 3D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer.
    Herbert C; Kwa W; Nakano S; James K; Moiseenko V; Wu J; Schellenberg D; Liu M
    Technol Cancer Res Treat; 2013 Dec; 12(6):511-6. PubMed ID: 23617285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients.
    Imano N; Kimura T; Kawahara D; Nishioka R; Fukumoto W; Kawano R; Kubo K; Katsuta T; Takeuchi Y; Nishibuchi I; Murakami Y; Horimasu Y; Masuda T; Fujitaka K; Hattori N; Nagata Y
    Jpn J Clin Oncol; 2021 Dec; 51(12):1729-1735. PubMed ID: 34625805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of using intravenous contrast-enhanced computed tomography (CT) scans in lung cancer treatment planning.
    Xiao J; Zhang H; Gong Y; Fu Y; Tang B; Wang S; Jiang Q; Li P
    Radiother Oncol; 2010 Jul; 96(1):73-7. PubMed ID: 20347496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients.
    Palma DA; van Sörnsen de Koste J; Verbakel WF; Vincent A; Senan S
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):974-8. PubMed ID: 20932655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?
    Kimura T; Matsuura K; Murakami Y; Hashimoto Y; Kenjo M; Kaneyasu Y; Wadasaki K; Hirokawa Y; Ito K; Okawa M
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):483-91. PubMed ID: 16904838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical appraisal of volumetric modulated arc therapy in stereotactic body radiation therapy for metastases to abdominal lymph nodes.
    Bignardi M; Cozzi L; Fogliata A; Lattuada P; Mancosu P; Navarria P; Urso G; Vigorito S; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1570-7. PubMed ID: 19880261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy.
    Kannarunimit D; Descovich M; Garcia A; Chen J; Weinberg V; Mcguinness C; Pinnaduwage D; Murnane J; Gottschalk AR; Yom SS
    Technol Cancer Res Treat; 2015 Feb; 14(1):49-60. PubMed ID: 24325136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison of two arc-based stereotactic body radiotherapy techniques for early-stage lung cancer.
    Liu H; Ye J; Kim JJ; Deng J; Kaur MS; Chen ZJ
    Med Dosim; 2015; 40(1):76-81. PubMed ID: 25499078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
    Ren C; Ji T; Liu T; Dang J; Li G
    Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques.
    Ong CL; Verbakel WF; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):437-42. PubMed ID: 21074878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC).
    Navarria P; Ascolese AM; Mancosu P; Alongi F; Clerici E; Tozzi A; Iftode C; Reggiori G; Tomatis S; Infante M; Alloisio M; Testori A; Fogliata A; Cozzi L; Morenghi E; Scorsetti M
    Radiother Oncol; 2013 Jun; 107(3):414-8. PubMed ID: 23725859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiological changes after stereotactic radiotherapy for stage I lung cancer.
    Dahele M; Palma D; Lagerwaard F; Slotman B; Senan S
    J Thorac Oncol; 2011 Jul; 6(7):1221-8. PubMed ID: 21623237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
    Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of I
    Zhang Z; Mao H; Wang X; Sheng W
    J Cancer Res Ther; 2020; 16(7):1560-1568. PubMed ID: 33565500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emphysema quantification on computed tomography and its value in predicting radiation pneumonitis in lung cancer treated by stereotactic body radiotherapy.
    Ye L; Zhang Y; Li T; Zhang X; Shi S; Zhao Q; Zeng Z; He J
    J Radiat Res; 2019 May; 60(3):371-379. PubMed ID: 30968939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity after central versus peripheral lung stereotactic body radiation therapy: a propensity score matched-pair analysis.
    Mangona VS; Aneese AM; Marina O; Hymas RV; Ionascu D; Robertson JM; Gallardo LJ; Grills IS
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):124-32. PubMed ID: 25442337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.